Issues & Trends

Zetema Decides to Issue 300억 Worth of Convertible Bonds and Contingent Preference Shares

Full-Scale Push into the Global Toxin Market Begins

[Edaily Reporter Kwon Oh-seok] #Zetema is set to raise a total of 300억 won through the issuance of convertible bonds (CBs) and convertible preferred shares (CPS). Zetema announced on the 19th that it held a board of directors meeting and decided on this funding plan.
(Photo courtesy of Zetema)

The issuance will proceed under terms of a 0% interest rate and a 10% premium over the reference share price, and the structure does not include a repricing clause that lowers the conversion price in the event of a decline in the stock price. The company emphasizes that, given the relatively favorable terms of the issuance, it has secured funds while minimizing dilution of existing shareholders’ stakes.
The raised funds are expected to be used to repay short-term debt and enhance financial stability. At the same time, the company explained that it has secured the financial capacity to invest in future global market expansion and the commercialization of new products.
Based on the funds secured, Zetema plans to accelerate its push into the global toxin market. In particular, in the Chinese market, the company has established a stable revenue base by signing a 10-year exclusive supply agreement worth approximately 5500억 원 with its local partner, Huadong Aesthetics (ZUOYI BIO). The company completed its Phase 3 clinical trial in China in May of this year and is currently undergoing the approval process with the National Medical Products Administration (NMPA). Commercialization is expected in the second half of 2027.
The company is also simultaneously pursuing entry into the U.S. market. Zetema has completed a U.S. Phase 2 clinical trial and is expanding its global business footprint by forging partnerships in Thailand, Turkey, and other regions.
A Zetema official stated, “This funding round focused on improving our financial structure and laying the groundwork for expansion into the Chinese market,” adding, “We will continue to achieve sustainable growth through the successful launch of Zetema DerToxin in the Chinese market and the expansion of our global business.”

Economy

Corporation

IT·Science

Economy

Lee Jae-yong Attends ‘Sun Valley,’ a Gathering of Billionaires… Expanding His Global AI Footprint

SamsungElectronics Chairman Lee Jae-yong is expected to attend the Sun Valley Conference, widely regarded as a social gathering for global business leaders.According to foreign media and business circ…
2026-07-05 17:15:06

Corporation

Hyundai Department Store Receives 'Top' Rating in SustainBest ESG Assessment

Hyundai Department Store ( HYUNDAIDEPARTMENTSTORECO.,LTD(069960)) announced on the 5th that it received the highest rating of “AA” in the first half of this year’s ESG evaluation conducted by SustainB…
2026-07-05 16:38:56

IT·Science

FDE: OpenAI, SAP, and Microsoft Have Joined the Fray… The Rules for Corporate AI Adoption Are Changing

The way global companies adopt artificial intelligence (AI) is rapidly shifting toward a field-based engineering approach. As the ability to successfully integrate AI into actual business systems beco…
2026-07-05 15:06:36